Market Cap: $66.47B
Market Cap: $66.47B

Cencora's new partnership in the CAR T-cell therapy space marks a significant move in enhancing access to innovative cancer treatments. The company, known for its focus on specialized healthcare distr…

Cencora, a key player in the pharmaceutical distribution industry, attracts attention as Vanguard Capital Management announces a substantial investment in the company. With a disclosed 7.3% stake repo…

Cencora, a leading company in health and specialty services, is poised for significant growth following its recent acquisition of EyeSouth’s retina business. This strategic move amplifies Cencora's pr…
Cencora Faces Leadership Transition with CFO Retirement Announcement Cencora announces the impending retirement of Chief Financial Officer James Cleary, effective June 30, 2026. Cleary has steered the…
Sunsweet Growers Inc. Welcomes New CFO to Drive Financial Strategy and Global Expansion Sunsweet Growers Inc., a leader in the dried fruit and beverage sectors, announces the appointment of Cor van de…
Sunsweet Growers Inc. Welcomes New CFO to Drive Financial Strategy Sunsweet Growers Inc., a leader in the dried fruit and beverage sectors, recently appoints Cor van den Berg as its new Chief Financia…
Cencora's Growth Strategy and Market Expansion Cencora, a prominent player in the healthcare supply chain, underscores its commitment to enhancing market presence through strategic growth initiatives…
Cencora's Commitment to Technology and Expansion Enhances Market Position Cencora, a prominent player in the pharmaceutical and healthcare logistics sector, is leveraging technology and market expansi…
Gubernatorial Race Highlights Complicated Dynamics of Opioid Crisis in New Jersey In the lead-up to New Jersey's gubernatorial election, the opioid crisis takes center stage as Democratic nominee Rep.…
Cencora Faces Scrutiny Amid Political Accusations Linked to Opioid Crisis In the competitive landscape of New Jersey politics, Rep. Mikie Sherrill, the Democratic gubernatorial nominee, amplifies her…
Cencora's Strategic Innovations Drive Market Success Cencora, a prominent player in the pharmaceutical supply chain, exemplifies the critical role of innovation in ensuring robust growth within the he…
Cencora's Strategic Position Amid Mixed Analyst Sentiments Cencora COR stands at a critical juncture in the pharmaceutical and healthcare sectors, characterized by a blend of optimism and caution from…
Cencora Navigates Complex Market Dynamics Amidst Mixed Analyst Ratings Cencora, a key player in the pharmaceutical and healthcare sectors, currently faces a multifaceted market environment as reflecte…
Cencora's Resilience in the Pharmaceutical Supply Chain Cencora, Inc. demonstrates remarkable strength in its third-quarter 2025 financial results, reporting an 8.7% increase in sales, amounting to $8…
Cencora's Third-Quarter Surge: Innovation and Market Positioning Drive Growth Cencora, Inc. announces impressive third-quarter financial results for 2025, showcasing a sales increase of 8.7% that elev…
Cencora's Analyst Evaluations Reflect Market Complexity Cencora COR, a prominent player in the healthcare logistics sector, finds itself under scrutiny from a diverse group of analysts, each offering…
Cencora's Diverse Analyst Evaluations Reflect Market Complexity In the past three months, Cencora COR has garnered attention from six different analysts, each offering a unique perspective on the comp…
Cencora COR: Analyst Opinions Reflect Diverse Perspectives on Future Performance Cencora COR, a prominent player in the pharmaceutical distribution sector, is currently under the scrutiny of six analy…
Cencora Sees Robust Growth in U.S. Healthcare Solutions Amid Mixed Financial Results Cencora, Inc. (COR) announces its financial results for the second quarter of 2025, showcasing a commendable 10.3%…
Cencora Strengthens Position with Strategic Share Repurchase Agreement Cencora, Inc. has initiated a significant share repurchase agreement with Walgreens Boots Alliance Holdings LLC, committing appro…
Cencora Strengthens Financial Position Through Strategic Share Repurchase Cencora, Inc. has recently announced a pivotal share repurchase agreement with Walgreens Boots Alliance Holdings LLC, involvin…
CoreSite Prepares for PTC 2025: Emphasizing Digital Infrastructure and Connectivity CoreSite, a prominent hybrid IT solutions provider and subsidiary of American Tower Corporation, gears up for its pa…
Cencora Expands Specialty Healthcare Footprint Through Acquisition of Retina Consultants of America Cencora, Inc., a leading global pharmaceutical solutions provider, bolsters its position in specialt…
Cencora Strengthens Specialty Healthcare with Acquisition of Retina Consultants of America Cencora, Inc. has finalized a definitive agreement to acquire Retina Consultants of America (RCA), a notable…
Cencora Bolsters Leadership Team with Strategic Appointments Cencora, Inc., a leading global pharmaceutical solutions provider, announces the strategic addition of Francois Mandeville and Pawan Verma…
Cencora Strengthens Leadership Team with Key Appointments Cencora, Inc., a leading global provider of pharmaceutical solutions, announces the strategic appointments of Francois Mandeville as Executive…